Nabiximols, a cannabis-based oral spray sold as Sativex, was reported to considerably ease spasticity — unusual muscle tightness or stiffness — in about two-thirds of the multiple sclerosis (MS) patients using it for three months in a real-world study in Germany.
For most patients, the treatment also eased pain and improved walking ability and sleep. After three months, about 62% of the study’s 51 evaluated patients reported that nabiximols’ use met their treatment goals “as expected” or “better than expected.”
“Nabiximols may be useful for MS patients with a poor response to usual spasticity medications,” researchers wrote in “Patient-reported benefits from nabiximols treatment in multiple sclerosis-related spasticity exceed conventional measures,” which was published as a short communication in Future Medicine.
Nabiximols, sold as Sativex, is available in Europe and Canada
Nabiximols is an oral spray that contains an equal amount of delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD), the main active compounds found in the cannabis plant. It is used as an add-on treatment to relieve muscle stiffness and spasms in patients who do not get enough relief with other spasticity medications. Read full article HERE….